Andrea Heslin Smiley - 20 May 2025 Form 4 Insider Report for ROCKWELL MEDICAL, INC. (RMTI)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
21 May 2025, 19:03:36 UTC
Prior SEC filing
14 Jun 2024
Next SEC filing
27 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Megan Timmins, Attorney-in-Fact for Andrea Heslin Smiley

Key filing fact

Andrea Heslin Smiley filed Form 4 for ROCKWELL MEDICAL, INC. (RMTI) on 21 May 2025.

Key facts

  • This page summarizes Andrea Heslin Smiley's Form 4 filing for ROCKWELL MEDICAL, INC. (RMTI).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 21 May 2025, 19:03.

Change

  • Previous filing in this sequence was filed on 14 Jun 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001703767 Primary reporting owner

Smiley Andrea Heslin

Relationship
Director
Address
C/O ROCKWELL MEDICAL, INC., 30142 WIXOM ROAD, WIXOM
Signature
/s/ Megan Timmins, Attorney-in-Fact for Andrea Heslin Smiley
Signature date
21 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RMTI transaction

Common Stock

Award

Transaction value
$0
Shares
+50,000
Change %
+54%
Price
$0.000000
Shares after
142,062
Date
20 May 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Restricted stock units vest on May 20, 2026, subject to the Reporting Person's continued service to the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .